Related Experiment Video

Updated: May 24, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer

Stefan Uhlmann1, Heiko Mannsperger, Jitao David Zhang

  • 1Division of Molecular Genome Analysis, German Cancer Research Center, Heidelberg, Germany.

Molecular Systems Biology
|February 16, 2012
PubMed

Insights

This study identified three microRNAs (miRNAs) that suppress breast cancer growth by targeting the EGFR cell-cycle network. These findings reveal novel miRNA regulatory patterns and potential therapeutic targets for cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The epidermal growth factor receptor (EGFR) pathway is crucial in breast cancer proliferation.
  • MicroRNAs (miRNAs) are known to regulate individual components of this pathway, but their global network coordination remains unclear.

Purpose of the Study:

  • To investigate the miRNome-level regulation of the EGFR protein network in breast cancer.
  • To identify specific miRNAs involved in coordinating this network and uncover regulatory patterns.

Main Methods:

  • Large-scale miRNA screening combined with high-throughput proteomics.
  • Network-based data analysis to identify miRNA-target interactions and regulatory patterns.
  • Validation of identified miRNAs as tumor suppressors.

Main Results:

  • miRNA-protein regulation is primarily driven by seed sequence complementarity to 3'-UTRs.
  • A novel network analysis revealed consistent patterns of miRNAs co-regulating proteins within functional modules.
  • Three miRNAs (miR-124, miR-147, miR-193a-3p) were identified as novel tumor suppressors targeting the EGFR cell-cycle network.

Conclusions:

  • miR-124, miR-147, and miR-193a-3p inhibit cell-cycle progression and proliferation in breast cancer by co-targeting EGFR-driven network proteins.
  • This study elucidates global miRNA regulatory mechanisms within the EGFR pathway.
  • Identified miRNAs represent potential therapeutic targets for breast cancer treatment.

More Related Videos

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...